rpsP Resolved · high auto-curated

H37Rv Rv2909c · MTBC0 mtbc0_003091 · 162 aa · 3237984–3238472 MTBC0 (-) · RefSeq NP_217425.1

Conflicting signals on this page. Two layers of this record disagree. Neither has been suppressed; what follows says what is known and what the disagreement means.
  • Both signals are true at once. The 10 PDB entries for this gene are WHOLE-RIBOSOME maps: the protein appears there as a subunit resolved inside the assembly, not as the subject of a study aimed at it. "An experimental structure exists" therefore does not mean, here, that somebody purified and published this protein, and it does not contradict the literature sweep's silence on its locus tag. Reviewed one by one on 2026-09-10. (structure vs unstudied, 2026-09-10)

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)30S ribosomal protein S16
MTBC0 PGAP re-annotation30S ribosomal protein S16
Revised (this work)30S ribosomal protein S16. Pfam: Ribosomal_S16 (PF00886.25).
Functional category (TubercuList)information pathways

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) named only in full text

No publication mentions this gene in its title or abstract — not under its H37Rv locus tag, not under its gene name, and not under any ortholog identifier. Its annotation rests on sequence/structure evidence, with no primary study behind it.

Named in the body of 114 paper(s) in Europe PMC full text, though in no title or abstract. Matched under Rv2909c (2), rpsP (109), MSMEG_2435 (3).

A hit does NOT mean functional characterisation -- it may be a mention in a genome-wide table or screen (e.g. a differential-expression supplementary table), exactly the mechanism that revealed the Rv3222c/Sarkar2021 co-induction. Restricted to hits CORROBORATED by the H37Rv tag itself, the gene name, or a substantial/multi-alias hit count -- single-low-count-ortholog-only hits were excluded pending individual review (cf. Rv0027/Mb0028, a confirmed collision unrelated to Mycobacterium). Coverage limit (P52.4, measured 2026-09-30): the body-text part of this search only sees articles whose full text Europe PMC holds, about 8-13 % of the TB literature published before 2005, 21 % for 2005-2009, 40 % for 2010-2014 and 66 % since 2020, so the absence of a hit says little about older mentions.

Also swept under the protein name “Small ribosomal subunit protein bS16”: nothing found. no abstract in PubMed contains this protein name in a mycobacterial context: the silence measured under the locus tag is confirmed under the protein name.

A protein name is not a gene identifier: a match may describe an orthologue in another species or a paralogue in H37Rv. Attribution here rests on a discriminant in the name (a paralogue number or a symbol) or on the locus tag / gene name being co-cited in the same abstract.

PubMed (E-utilities), sweep by UniProt PROTEIN NAME and its spelling variants (parentheses/subscript forms), each hit verified by literal match in title+abstract. phase110, 2026-08-10

Scope of the sweep: What was actually swept: the H37Rv locus tag and the ortholog locus tags (M. bovis Mb…, M. marinum MMAR_…, M. smegmatis MSMEG_…, M. leprae ML…, M. abscessus MAB_…), plus the gene name where one exists. NOT swept: protein and enzyme names, including family shorthands such as Ldt(Mt4) or VapC28, and their orthographic variants. An absent locus-tag mention is therefore evidence about the TAG, and only indirect evidence about the protein (P18.14). Extended on 2026-08-10 (P18.20): the UniProt protein name and its spelling variants were swept as well; the result is in `protein_name_sweep`.

155 records returned by the alias sweep — none names this gene

Searched as: Rv2909c, rpsP, Mb2933c, ML1618c, MMAR_1799, MSMEG_2435, MAB_3229c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

This count is not a count of papers about this gene. The alias sweep of 2026-09-07 returned 155 publication(s) for this gene, and NOT ONE of them names it in its title, abstract or author keywords: the match falls elsewhere in the PubMed record (a journal name, a DOI, an affiliation, an author name). A PubMed count is not an attribution. The count is kept visible rather than deleted, but it does not contradict the statement above that no publication mentions this gene, and it must not be read as evidence that the gene is studied.

PublicationJournalYear
Predictors of mortality among individuals with advanced HIV disease in a contemporary Brazilian cohort. doi:10.26633/RPSP.2026.36 does not name it Rev Panam Salud Publica 2026
Spatiotemporal trends in and challenges of addressing tuberculosis in Brazil before and after the COVID-19 pandemic, 2001-2023. doi:10.26633/RPSP.2026.10 does not name it Rev Panam Salud Publica 2026
[Effectiveness of a community strategy for the treatment of tuberculosis in vulnerable contexts in the city of Buenos AiresEfetividade de uma estratégia de base comunitária para o tratamento da tuberculose em contextos vulneráveis da Cidade de Buenos Aires]. doi:10.26633/RPSP.2025.100 does not name it Rev Panam Salud Publica 2025
[Social protection strategies for people with tuberculosis in Latin America: (re)thinking policies and practicesEstrategias de protección social para las personas con tuberculosis en América Latina: (re)pensar las políticas y las prácticas]. doi:10.26633/RPSP.2025.78 does not name it Rev Panam Salud Publica 2025
Predictors of mortality among individuals with advanced HIV disease in a contemporary Brazilian cohort. doi:10.26633/RPSP.2025.36 does not name it Rev Panam Salud Publica 2025
[Telephone surveys for the study of catastrophic costs due to tuberculosis in Colombia: a novel toolPesquisas telefônicas para um estudo de custos catastróficos da tuberculose na Colômbia: uma ferramenta inovadora]. doi:10.26633/RPSP.2024.88 does not name it Rev Panam Salud Publica 2024
Trends in tuberculosis incidence and mortality coefficients in Brazil, 2011-2019: analysis by inflection points. doi:10.26633/RPSP.2023.152 does not name it Rev Panam Salud Publica 2023
Effects of public health emergencies of international concern on disease control: a systematic review. doi:10.26633/RPSP.2023.74 does not name it Rev Panam Salud Publica 2023
High level of infection prevention and control in surveyed hospitals in Colombia, 2021. doi:10.26633/RPSP.2023.70 does not name it Rev Panam Salud Publica 2023
Multidrug-resistant Salmonella spp. in fecal samples of pigs with suspected salmonellosis in Antioquia, Colombia, 2019-2021. doi:10.26633/RPSP.2023.46 does not name it Rev Panam Salud Publica 2023
Prevalence and antimicrobial resistance of Escherichia coli and Salmonella spp. in animal feed in Colombia. doi:10.26633/RPSP.2023.57 does not name it Rev Panam Salud Publica 2023
Whole-genome sequencing for surveillance of antimicrobial resistance in Ecuador: present and future implications. doi:10.26633/RPSP.2023.8 does not name it Rev Panam Salud Publica 2023
Antibiotic consumption in secondary and tertiary hospitals in Colombia: national surveillance from 2018-2020. doi:10.26633/RPSP.2023.63 does not name it Rev Panam Salud Publica 2023
Epidemiology of antimicrobial resistance in bacteria isolated from inpatient and outpatient samples, Ecuador, 2018. doi:10.26633/RPSP.2023.14 does not name it Rev Panam Salud Publica 2023
High levels of antimicrobial resistance in Escherichia coli and Salmonella from poultry in Ecuador. doi:10.26633/RPSP.2023.15 does not name it Rev Panam Salud Publica 2023
Bloodstream infections and antibiotic resistance at a regional hospital, Colombia, 2019-2021. doi:10.26633/RPSP.2023.18 does not name it Rev Panam Salud Publica 2023
Colistin resistance in Escherichia coli and Klebsiella pneumoniae in humans and backyard animals in Ecuador. doi:10.26633/RPSP.2023.48 does not name it Rev Panam Salud Publica 2023
[National and regional social observatories of tuberculosis in eight countries in Latin America and the CaribbeanObservatórios sociais nacionais e regional de tuberculose em oito países da América Latina e do Caribe]. doi:10.26633/RPSP.2022.163 does not name it Rev Panam Salud Publica 2022
[Adaptation and validation of EMPODERA-TB to evaluate empowerment of patients with pulmonary tuberculosisAdaptação e validação do instrumento EMPODERA-TB para avaliar o empoderamento em pacientes com tuberculose pulmonar]. doi:10.26633/RPSP.2022.168 does not name it Rev Panam Salud Publica 2022
Towards a smoke-free world? South America became the first 100% smoke-free subregion in the Americas. doi:10.26633/RPSP.2022.103 does not name it Rev Panam Salud Publica 2022
[Tuberculosis and diabetes comorbidity in Brazil, 2012-2018: exploratory spatial data analysis and statistical modelingLa comorbilidad tuberculosis-diabetes en Brasil, 2012-2018: análisis exploratorio de la distribución espacial y modelización estadística]. doi:10.26633/RPSP.2022.51 does not name it Rev Panam Salud Publica 2022
[Epidemiological behavior of leprosy in several Latin American countries, 2011-2020Comportamento epidemiológico da hanseníase em vários países da América Latina, 2011-2020]. doi:10.26633/RPSP.2022.14 does not name it Rev Panam Salud Publica 2022
COVID-19 and inequities in the Americas: lessons learned and implications for essential health services. doi:10.26633/RPSP.2021.130 does not name it Rev Panam Salud Publica 2021
[Combined use of serologic markers and spatial analysis for epidemiological surveillance of leprosyUso conjunto de los marcadores serológicos y del análisis espacial en la vigilancia epidemiológica de la lepra]. doi:10.26633/RPSP.2021.129 does not name it Rev Panam Salud Publica 2021
Patient- and provider-related factors in the success of multidrug-resistant tuberculosis treatment in Colombia. doi:10.26633/RPSP.2021.74 does not name it Rev Panam Salud Publica 2021
[Patient- and provider-related factors in the success of multidrug tuberculosis treatment in ColombiaFatores de êxito do tratamento da tuberculose multirresistente relacionados com o paciente e com a equipe de saúde na Colômbia]. doi:10.26633/RPSP.2021.5 does not name it Rev Panam Salud Publica 2021
[National Network for Knowledge Management, Research, and Innovation in Tuberculosis in ColombiaRede Nacional de Gestão do Conhecimento, Pesquisa e Inovação em tuberculose na Colômbia]. doi:10.26633/RPSP.2021.23 does not name it Rev Panam Salud Publica 2021
Tuberculosis care cascade for the indigenous population in Colombia: an operational research study. doi:10.26633/RPSP.2021.20 does not name it Rev Panam Salud Publica 2021
Evaluation of the first level of care for tuberculosis control in Buenos Aires, Argentina. doi:10.26633/RPSP.2021.22 does not name it Rev Panam Salud Publica 2021
Primary and acquired multidrug-resistant tuberculosis: Predictive factors for unfavorable treatment outcomes in Rio de Janeiro, 2000-2016. doi:10.26633/RPSP.2020.178 does not name it Rev Panam Salud Publica 2020
[Social determinants and the Sustainable Development Goals' tuberculosis target in the AmericasDeterminantes sociais e a meta para a tuberculose dos Objetivos de Desenvolvimento Sustentável nas Américas]. doi:10.26633/RPSP.2020.153 does not name it Rev Panam Salud Publica 2020
[Evaluation of the first level of care for tuberculosis control in Buenos Aires, ArgentinaAvaliação da atenção primária à saúde no controle da tuberculose em Buenos Aires, Argentina]. doi:10.26633/RPSP.2020.156 does not name it Rev Panam Salud Publica 2020
[Tuberculosis care cascade for the indigenous population in Colombia: an operational research studyCascata de atenção da tuberculose para os povos indígenas na Colômbia: pesquisa operacional]. doi:10.26633/RPSP.2020.150 does not name it Rev Panam Salud Publica 2020
[Epidemiological profile of extensively drug-resistant tuberculosis in Peru, 2013-2015Perfil epidemiológico da tuberculose extremamente resistente no Peru, 2013-2015]. doi:10.26633/RPSP.2020.29 does not name it Rev Panam Salud Publica 2020
[Factors associated with unsuccessful treatment of patients with drug-sensitive tuberculosis in Paraguay]. doi:10.26633/RPSP.2020.89 does not name it Rev Panam Salud Publica 2020
Tuberculosis and HIV coinfection and related collaborative activities in Latin America and the Caribbean. doi:10.26633/RPSP.2020.43 does not name it Rev Panam Salud Publica 2020
[Infectious and parasitic diseases in Brazil, 2010 to 2017: considerations for surveillanceEnfermedades infecciosas y parasitarias en Brasil de 2010 a 2017: aspectos para la vigilancia sanitaria]. doi:10.26633/RPSP.2020.10 does not name it Rev Panam Salud Publica 2020
[Low detection rate and therapeutic success of tuberculosis in a prison in EcuadorBaixo recrutamento de pacientes e sucesso no tratamento da tuberculose em uma prisão do Equador]. doi:10.26633/RPSP.2019.106 does not name it Rev Panam Salud Publica 2019
[Prevalence of comorbidity tuberculosis and diabetes mellitus in Paraguay, 2016 and 2017Prevalência de comorbidade tuberculose-diabetes mellitus no Paraguai, 2016 e 2017]. doi:10.26633/RPSP.2019.105 does not name it Rev Panam Salud Publica 2019
[Tuberculosis in children and adolescents in Ecuador: analysis of reporting, disease characteristics and treatment outcomeTuberculose em crianças e adolescentes no Equador: análise da notificação, características da doença e resultados do tratamento]. doi:10.26633/RPSP.2019.104 does not name it Rev Panam Salud Publica 2019
Factors associated with mortality in persons co-infected with tuberculosis and HIV in Suriname: a retrospective cohort study. doi:10.26633/RPSP.2019.103 does not name it Rev Panam Salud Publica 2019
[Factors associated with tuberculosis mortality in Paraguay, 2015-2016Fatores associados à mortalidade por tuberculose no Paraguai, 2015-2016]. doi:10.26633/RPSP.2019.102 does not name it Rev Panam Salud Publica 2019
Operational research in the context of advancing towards tuberculosis elimination in the Americas. doi:10.26633/RPSP.2019.101 does not name it Rev Panam Salud Publica 2019
[Factors associated with completion of isoniazid preventive therapy in children in Quito, Ecuador (2014-2016 and 2018)Fatores associados à adesão à terapia preventiva com isoniazida em crianças de Quito, Equador (2014-2016 e 2018)]. doi:10.26633/RPSP.2019.97 does not name it Rev Panam Salud Publica 2019
[Loss to follow-up in patients treated for multidrug-resistant tuberculosis in EcuadorA Perda de seguimento de pacientes tratados para tuberculose multirresistente a medicamentos no Equador]. doi:10.26633/RPSP.2019.91 does not name it Rev Panam Salud Publica 2019
Determinants of sputum smear nonconversion in smear-positive pulmonary tuberculosis patients in Suriname, 2010 - 2015. doi:10.26633/RPSP.2019.86 does not name it Rev Panam Salud Publica 2019
[Co-management of tuberculosis and diabetes: an integrative reviewManejo integrado de la tuberculosis y la diabetes: revisión integrativa]. doi:10.26633/RPSP.2019.21 does not name it Rev Panam Salud Publica 2019
[Control and management strategies in multidrug-resistant tuberculosis: literature reviewEstrategias de control y atención de la tuberculosis multirresistente: una revisión de la literatura]. doi:10.26633/RPSP.2019.20 does not name it Rev Panam Salud Publica 2019
[Prevalence of tuberculosis in incarcerated populations: systematic review and meta-analysisPrevalencia de tuberculosis en la población privada de libertad: revisión sistemática y metanálisis]. doi:10.26633/RPSP.2019.16 does not name it Rev Panam Salud Publica 2019
Factors associated with delays in pulmonary tuberculosis diagnosis and treatment initiation in Cali, Colombia. doi:10.26633/RPSP.2019.14 does not name it Rev Panam Salud Publica 2019
Health care workers' recommendations for strengthening tuberculosis infection control in the Dominican Republic. doi:10.26633/RPSP.2018.169 does not name it Rev Panam Salud Publica 2018
Better use of available radiology resources for women's health in Latin America and the Caribbean. doi:10.26633/RPSP.2018.115 does not name it Rev Panam Salud Publica 2018
Effect of inpatient and outpatient care on treatment outcome in tuberculosis: a cohort study. doi:10.26633/RPSP.2018.112 does not name it Rev Panam Salud Publica 2018
[International cooperation: drugs donated by the Brazilian government, 2005-2016Cooperación internacional: donaciones de medicamentos del gobierno brasileño entre el 2005 y el 2016]. doi:10.26633/RPSP.2018.67 does not name it Rev Panam Salud Publica 2018
[Response capacity and challenges of the Cuban health system against communicable diseasesCapacidade de resposta e desafios do sistema de saúde cubano contra doenças transmissíveis]. doi:10.26633/RPSP.2018.30 does not name it Rev Panam Salud Publica 2018
A systematic review of economic evaluations of interventions to tackle tuberculosis in homeless people. doi:10.26633/RPSP.2018.40 does not name it Rev Panam Salud Publica 2018
Clinical challenges in the era of multiple and extensively drug-resistant tuberculosis. doi:10.26633/RPSP.2017.167 does not name it Rev Panam Salud Publica 2017
[Burden of tuberculosis attributable to diabetes in the adult population of the AmericasCarga de tuberculose atribuível à diabetes em população adulta nas Américas]. doi:10.26633/RPSP.2017.125 does not name it Rev Panam Salud Publica 2017
Hospital-based tuberculosis control activities in five cities of Latin America. doi:10.26633/RPSP.2017.95 does not name it Rev Panam Salud Publica 2017
[Evaluation of implementation of the protocol for managing tuberculosis/ human immunodeficiency virus coinfection in specialized care services in ceará state]. doi:10.26633/RPSP.2017.48 does not name it Rev Panam Salud Publica 2017
[Access barriers to comprehensive care for people affected by tuberculosis and human immunodeficiency virus coinfection in Peru, 2010-2015]. doi:10.26633/RPSP.2017.23 does not name it Rev Panam Salud Publica 2017
[Antituberculosis-drug resistance in the border of Brazil with Paraguay and Bolivia]. doi:10.26633/RPSP.2017.9 does not name it Rev Panam Salud Publica 2017
Scale-up of collaborative TB/HIV activities in Guyana. doi:10.26633/RPSP.2017.6 does not name it Rev Panam Salud Publica 2017
[Introduction of rapid syphilis and HIV testing in prenatal care in Colombia: qualitative analysis]. does not name it Rev Panam Salud Publica 2016
[Profile of transvestites and transgender women: tuberculosis and HIV/AIDS in the city of São Paulo]. does not name it Rev Panam Salud Publica 2016
HIV/AIDS prevention, care and treatment in the Region of the Americas: achievements, challenges and perspectives. does not name it Rev Panam Salud Publica 2016
Operational research to strengthen tuberculosis control in the Americas. does not name it Rev Panam Salud Publica 2016
Trends in tuberculosis notification and treatment outcomes in prisons: a country-wide assessment in El Salvador from 2009-2014. does not name it Rev Panam Salud Publica 2016
HIV testing, antiretroviral therapy, and treatment outcomes in new cases of tuberculosis in Brazil, 2011. does not name it Rev Panam Salud Publica 2016
Contrasting trends of tuberculosis in the cities of San Pedro Sula and Tegucigalpa, Honduras, 2005-2014. does not name it Rev Panam Salud Publica 2016
Implementation of the national tuberculosis guidelines on culture and drug sensitivity testing in Guatemala, 2013. does not name it Rev Panam Salud Publica 2016
Culture and drug susceptibility testing among previously treated tuberculosis patients in the Dominican Republic, 2014. does not name it Rev Panam Salud Publica 2016
Use and evaluation of a line probe assay in patients with tuberculosis in Peru: 2011-2013. does not name it Rev Panam Salud Publica 2016
Tuberculosis among indigenous municipalities in Mexico: analysis of case notification and treatment outcomes between 2009 and 2013. does not name it Rev Panam Salud Publica 2016
Quality of tuberculosis care at different levels of health care in Brazil in 2013. does not name it Rev Panam Salud Publica 2016
Culture and drug sensitivity testing among patients with pulmonary tuberculosis in Mexico: national data for 2009-2013. does not name it Rev Panam Salud Publica 2016
Monitoring delays in diagnosis of pulmonary tuberculosis in eight cities in Colombia. does not name it Rev Panam Salud Publica 2016
Determinants of tuberculosis in countries of Latin America and the Caribbean. does not name it Rev Panam Salud Publica 2016
[South-South cooperation to strengthen the medicines control laboratories of the Caribbean community (CARICOM)]. does not name it Rev Panam Salud Publica 2016
[The epidemiological advantage of preferential targeting of tuberculosis control at the poor]. does not name it Rev Panam Salud Publica 2015
Social determinants and inequalities in tuberculosis incidence in Latin America and the Caribbean. does not name it Rev Panam Salud Publica 2015
[Design and semantic validation of a new instrument to assess policy transfer of directly observed treatment for tuberculosis]. does not name it Rev Panam Salud Publica 2015
Determinants of tuberculosis in Brazil: from conceptual framework to practical application. does not name it Rev Panam Salud Publica 2015
Patient attrition from the HIV antiretroviral therapy program at two hospitals in Haiti. does not name it Rev Panam Salud Publica 2014
Tuberculosis and living conditions in Salvador, Brazil: a spatial analysis. does not name it Rev Panam Salud Publica 2014
[Tuberculosis and social inequity in health: an ecological study using multivariate statistical techniques, São Paulo, Brazil]. does not name it Rev Panam Salud Publica 2014
[Social determinants and self-reported tuberculosis: National Research by Household Sample, metropolitan areas, Brazil]. does not name it Rev Panam Salud Publica 2013
[Tuberculosis in Amazonian municipalities of the Brazil-Colombia-Peru-Venezuela border: epidemiological situation and risk factors associated with treatment default]. does not name it Rev Panam Salud Publica 2013
[Eliminating tuberculosis one neighborhood at a time]. does not name it Rev Panam Salud Publica 2013
Tuberculosis patients in the Dominican Republic face severe direct and indirect costs and need social protection. doi:10.1590/s1020-49892013000500004 does not name it Rev Panam Salud Publica 2013
[Tuberculosis and socioeconomic indicators: systematic review of the literature]. doi:10.1590/s1020-49892013000400009 does not name it Rev Panam Salud Publica 2013
[The National Tuberculosis Research Agenda in Peru, 2011-2014]. doi:10.1590/s1020-49892013000200011 does not name it Rev Panam Salud Publica 2013
[Tuberculosis in indigenous peoples in the Brazilian Amazon: an epidemiological study in the Upper Rio Negro region]. doi:10.1590/s1020-49892013000100004 does not name it Rev Panam Salud Publica 2013
Feasibility study of a smoking cessation intervention in Directly Observed Therapy Short-Course tuberculosis treatment clinics in Rio de Janeiro, Brazil. does not name it Rev Panam Salud Publica 2012
[Cost-effectiveness of an alternative tuberculosis treatment: home-based guardian monitoring of patients]. doi:10.1590/s1020-49892012000900002 does not name it Rev Panam Salud Publica 2012
Tuberculosis testing among populations with high HIV risk in Tijuana, Baja California, Mexico. doi:10.1590/s1020-49892012000700005 does not name it Rev Panam Salud Publica 2012
[Delays in the diagnosis of tuberculosis in a town at the triple border of Brazil, Paraguay, and Argentina]. doi:10.1590/s1020-49892012000600003 does not name it Rev Panam Salud Publica 2012
Multidrug-resistant tuberculosis in Port-au-Prince, Haiti. doi:10.1590/s1020-49892012000300006 does not name it Rev Panam Salud Publica 2012
Predictive factors for repetition of the tuberculin test after a nonreactive test in patients with HIV/AIDS. doi:10.1590/s1020-49892012000200005 does not name it Rev Panam Salud Publica 2012
[Surveillance of resistance to antitubercular drugs in Cuba, 2000-2009]. doi:10.1590/s1020-49892011001200020 does not name it Rev Panam Salud Publica 2011
Situation of bovine tuberculosis in Ecuador. doi:10.1590/s1020-49892011000900013 does not name it Rev Panam Salud Publica 2011
[Prevalence of respiratory symptoms in areas of the Federal District, Brazil]. does not name it Rev Panam Salud Publica 2011
Tuberculosis transmission across the United States-Mexico border. doi:10.1590/s1020-49892011000100009 does not name it Rev Panam Salud Publica 2011
Health status of southern Arizona border counties: a Healthy Border 2010 midterm review. does not name it Rev Panam Salud Publica 2010
[Tuberculosis incidence strata in Cuban municipalities: 1999-2002 and 2003-2006]. doi:10.1590/s1020-49892010001000006 does not name it Rev Panam Salud Publica 2010
Comparison of the QuantiFERON®-TB Gold assay and tuberculin skin test to detect latent tuberculosis infection among target groups in Trinidad & Tobago. doi:10.1590/s1020-49892010000700006 does not name it Rev Panam Salud Publica 2010
[Hansen's disease, social conditions, and deforestation in the Brazilian Amazon]. doi:10.1590/s1020-49892010000400005 does not name it Rev Panam Salud Publica 2010
Participatory communication for tuberculosis control in prisons in Bolivia, Ecuador, and Paraguay. doi:10.1590/s1020-49892010000300003 does not name it Rev Panam Salud Publica 2010
[The role of health care providers in the late diagnosis of pulmonary tuberculosis among adults in Medellín, Colombia]. doi:10.1590/s1020-49892010000200001 does not name it Rev Panam Salud Publica 2010
Field and laboratory preparedness: challenges to rolling out new multidrug-resistant tuberculosis diagnostics. doi:10.1590/s1020-49892009000800004 does not name it Rev Panam Salud Publica 2009
[Health education in schools in Argentina: an art contest as a motivating activity]. doi:10.1590/s1020-49892009000200013 does not name it Rev Panam Salud Publica 2009
Knowledge and practices of medical students to prevent tuberculosis transmission in Rio de Janeiro, Brazil. doi:10.1590/s1020-49892008001000006 does not name it Rev Panam Salud Publica 2008
New drugs in Brazil: do they meet Brazilian public health needs? doi:10.1590/s1020-49892008000700005 does not name it Rev Panam Salud Publica 2008
The meaning and consequences of tuberculosis for an at-risk urban group in Ecuador. doi:10.1590/s1020-49892008000300006 does not name it Rev Panam Salud Publica 2008
[Study of rifampin and dapsone resistance in three patients with recurring leprosy]. doi:10.1590/s1020-49892008000200001 does not name it Rev Panam Salud Publica 2008
[Efficiency of outpatient clinics in Matanzas, Cuba, using data envelopment analysis]. doi:10.1590/s1020-49892007000700004 does not name it Rev Panam Salud Publica 2007
The relationship between nutritional and sociodemographic factors and the likelihood of children in the Dominican Republic having a BCG scar. doi:10.1590/s1020-49892007000500004 does not name it Rev Panam Salud Publica 2007
[The quality of radiology services in five Latin American countries]. doi:10.1590/s1020-49892006000800008 does not name it Rev Panam Salud Publica 2006
Tuberculin skin reactivity after neonatal BCG vaccination in preterm infants in Minas Gerais, Brazil, 2001-2002. doi:10.1590/s1020-49892006000600006 does not name it Rev Panam Salud Publica 2006
Prevalence of human immunodeficiency virus infection in patients with pulmonary tuberculosis at the National Chest Hospital in Jamaica. doi:10.1590/s1020-49892006000100006 does not name it Rev Panam Salud Publica 2006
[Predictive factors for noncompliance with tuberculosis treatment in an endemic region of Peru]. doi:10.1590/s1020-49892005000600003 does not name it Rev Panam Salud Publica 2005
[Dropout from tuberculosis treatment in Nicaragua: the results of a comparative study]. doi:10.1590/s1020-49892005000400008 does not name it Rev Panam Salud Publica 2005
Current strategy for leprosy control in Brazil: time to pursue alternative preventive strategies? doi:10.1590/s1020-49892004001100014 does not name it Rev Panam Salud Publica 2004
[Multiple drug resistance: a threat for tuberculosis control]. doi:10.1590/s1020-49892004000700013 does not name it Rev Panam Salud Publica 2004
Tuberculosis along the United States-Mexico border, 1993-2001. doi:10.1590/s1020-49892004000700004 does not name it Rev Panam Salud Publica 2004
[Health, equity, and the Millennium Development Goals]. doi:10.1590/s1020-49892004000600012 does not name it Rev Panam Salud Publica 2004
[Factors associated with the presence of tuberculosis in patients with acquired immunodeficiency syndrome in Cuba]. doi:10.1590/s1020-49892004000500010 does not name it Rev Panam Salud Publica 2004
Infectious disease risks from dead bodies following natural disasters. doi:10.1590/s1020-49892004000500004 does not name it Rev Panam Salud Publica 2004
[Mortality due to infectious and parasitic diseases in the elderly in Brazil]. doi:10.1590/s1020-49892004000400003 does not name it Rev Panam Salud Publica 2004
[Tuberculosis among city jail inmates in Campinas, São Paulo, Brazil]. doi:10.1590/s1020-49892004000300008 does not name it Rev Panam Salud Publica 2004
[Educational strategy for improving patient compliance with the tuberculosis treatment regimen in Chiapas, Mexico]. doi:10.1590/s1020-49892003001100005 does not name it Rev Panam Salud Publica 2003
[Tuberculin reactivity among ninth-grade schoolchildren in the city of Havana, Cuba]. doi:10.1590/s1020-49892003000800008 does not name it Rev Panam Salud Publica 2003
Clinical and demographic features of HIV infection in El Salvador. doi:10.1590/s1020-49892003000400008 does not name it Rev Panam Salud Publica 2003
Tuberculin reactivity in a population of schoolchildren with high BCG vaccination coverage. doi:10.1590/s1020-49892003000400003 does not name it Rev Panam Salud Publica 2003
Overview of social inequalities in health in the region of the Americas, using various methodological approaches. doi:10.1590/s1020-49892002001200005 does not name it Rev Panam Salud Publica 2002
[Premature death from infectious diseases in Spain, 1908-1995]. doi:10.1590/s1020-49892002001000007 does not name it Rev Panam Salud Publica 2002
[Developing and using a PCR test to detect subclinical Mycobacterium leprae infection]. doi:10.1590/s1020-49892002000400004 does not name it Rev Panam Salud Publica 2002
[A mathematical model of the annual risk of tuberculosis infection in Cali, Colombia]. does not name it Rev Panam Salud Publica 2002
[Preventing opportunistic infections in patients infected with the human immunodeficiency virus]. does not name it Rev Panam Salud Publica 2001
[Prognostic factors for pulmonary tuberculosis outcome in Recife, Pernambuco, Brazil]. doi:10.1590/s1020-49892001000600003 does not name it Rev Panam Salud Publica 2001
Evolution of the health sector and tuberculosis control in Brazil. doi:10.1590/s1020-49892001000500004 does not name it Rev Panam Salud Publica 2001
[Seeking tuberculosis care in Chiapas, Mexico]. doi:10.1590/s1020-49892001000500001 does not name it Rev Panam Salud Publica 2001
The use of socioeconomic factors in mapping tuberculosis risk areas in a city of northeastern Brazil. doi:10.1590/s1020-49892000001100005 does not name it Rev Panam Salud Publica 2000
[[Evaluation of the tuberculin reaction in health occupation students] ]. doi:10.1590/s1020-49892000000900007 does not name it Rev Panam Salud Publica 2000
Patients with tuberculosis in Bolivia: why do they die? doi:10.1590/s1020-49892000000800001 does not name it Rev Panam Salud Publica 2000
[Detection of Mycobacterium tuberculosis by polymerase chain reaction in a selected population in northwestern Mexico]. doi:10.1590/s1020-49892000000600006 does not name it Rev Panam Salud Publica 2000
The shape of the HIV/AIDS epidemic in Puerto Rico. doi:10.1590/s1020-49892000000600004 does not name it Rev Panam Salud Publica 2000
[Tuberculosis recurrence and its risk factors]. doi:10.1590/s1020-49892000000400004 does not name it Rev Panam Salud Publica 2000
[Infectious and parasitic diseases in Brazil: a decade of transition]. doi:10.1590/s1020-49891999000700004 does not name it Rev Panam Salud Publica 1999
[Mycobacterial infections in HIV-infected patients in Cali, Colombia]. doi:10.1590/s1020-49891999000900004 does not name it Rev Panam Salud Publica 1999
[Public laboratories for vaccine production: a new paradigm]. does not name it Rev Panam Salud Publica 1998
[Health service coverage in Latin America and the Caribbean]. doi:10.1590/s1020-49891998001100003 does not name it Rev Panam Salud Publica 1998
[Determination of the dispersion of microorganisms in the course of dental surgical activity]. doi:10.1590/s1020-49891998000200003 does not name it Rev Panam Salud Publica 1998
[Control of tuberculosis in refugees and displaced]. does not name it Rev Panam Salud Publica 1997
[Usefulness of studies on antitubercular drug resistance]. does not name it Rev Panam Salud Publica 1997

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Intrinsic disorder (sequence + structure) partially disordered

Predicted disorder32% of residues (metapredict) · mean AlphaFold pLDDT 76.4
Disordered regions1 IDR(s), longest 52 aa [110-162]

carries a substantial disordered region (52/162 residues); disorder is a property, not a function

A property (biophysics), not a function. No LLPS/condensate claim is made from disorder alone. Verdict unchanged. Source: metapredict v3 (Emenecker/Holehouse) per-residue disorder + AlphaFold mean pLDDT (annotation_mtbc P16.13).

CRISPRi vulnerability

Vulnerability index -13.61 (95% CI -15.86 to -11.32). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionInvolved in translation mechanism.

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb2933c · 100.0% identity
M. leprae ML1618c · 90.9% identity
M. marinum MMAR_1799 · 81.5% identity
M. smegmatis MSMEG_2435 · 83.3% identity
M. orygis RJtmp_003000 · 100.0% identity
M. abscessus MAB_3229c · 84.1% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WH53 SwissProt · reviewed · Evidence at protein level
UniProt nameSmall ribosomal subunit protein bS16

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category J Translation, ribosomal structure and biogenesis
Preferred namerpsP
eggNOG descriptionBelongs to the bacterial ribosomal protein bS16 family
Orthologous groupCOG0228
KEGG orthology K02959
KEGG pathways map03010
KEGG modules M00178
Gene Ontology (50) GO:0003674, GO:0003735, GO:0005198, GO:0005575, GO:0005622, GO:0005623, GO:0005737, GO:0005840, GO:0005886, GO:0006412, GO:0006518, GO:0006807 +38 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.332 · quasi-invariant (2 sites), pN/pS underpowered
Polymorphic sites (≥ 0.1% of strains) 1 synonymous, 1 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 92.0% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 12/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 73.9%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) GD — not strictly essential

The two screens disagree on this gene: Tn-seq says growth-defect (insertions tolerated, NOT essential) (GD), CRISPRi says essential.

Two genome-wide screens disagree on this gene, and both are kept as they stand. They do not measure the same thing: the Tn-seq call (DeJesus 2017) reports tolerance to transposon insertion across the ORF, the CRISPRi call (Bosch 2021) reports tolerance to partial knockdown. A gene can absorb an insertion and still be required at full dosage, or the reverse. Here the CRISPRi estimate is a confident one (its `certain` flag is set, vulnerability index -13.608), so the disagreement is a genuine methodological tension rather than a weak fit. Atlas-wide, 89 gene(s) fall in this exact stratum, out of 193 showing this direction of disagreement.

DeJesus 2017 callGD · growth-defect
What the call meansgrowth-defect: insertions tolerated but fitness reduced; NOT essential
TA sites (Himar1) 7 in the ORF — 0 in the essential state, 7 growth-defect, 0 non-essential, 0 growth-advantage. Saturation 0.143, mean read count 41. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 7 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.
Caveat`essential: true` here is the broad union (ES+ESD+GD) kept for backward compatibility; this gene is NOT strictly essential. Read n_sites_* before writing anything about essentiality. Read with some caution: only 7 TA (Himar1) sites in the whole ORF (atlas median 13). The DeJesus 2017 call rests on fewer independent observations than for a longer gene. If this gene overlaps a neighbour (see Genomic-neighbour overlap section below), some of these 7 sites may fall inside the neighbour's ORF rather than its own, leaving even fewer truly informative sites than the raw count suggests. (P20.3)

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Proteomics (mass spectrometry) detected

MS detectiondetected in 14 of 16 independent MS datasets
Integrated abundance1980.0 ppm · rank 78/3519 (97.8th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length162 aa
Molecular weight17.4 kDa
Theoretical pI9.87
GRAVY-0.618 (hydrophilic)
Aliphatic index77.9
Aromaticity0.043
Instability index40.5 (unstable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
Ribosomal_S16PF00886.25 1.1e-229–67 Ribosomal protein S16

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 7sfr (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 10 solved

PDBMethodResolutionCoverage
7sfr Electron Microscopy 2.6 Å 100%
7kgb Electron Microscopy 2.7 Å 100%
7mt7 Electron Microscopy 2.71 Å 100%
7mt2 Electron Microscopy 2.76 Å 100%
7msm Electron Microscopy 2.79 Å 100%
7mt3 Electron Microscopy 2.8 Å 100%
7msc Electron Microscopy 2.97 Å 100%
7msz Electron Microscopy 3.1 Å 100%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (10 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 76.4

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
8whx-assembly1_q 1.00 0.95 0.66 0.94 88% 69% / 99% 2.6e-18 sig 8whx-assembly1_q Cryo- EM structure of Mycobacterium smegmatis 70S ribosome and RafH.
7msc-assembly1_p 1.00 0.93 0.66 0.93 100% 70% / 100% 2.6e-18 sig 7msc-assembly1_p Mtb 70SIC in complex with MtbEttA at Pre_R0 state
5o5j-assembly1_P 1.00 0.95 0.66 0.94 88% 69% / 99% 6.8e-17 sig 5o5j-assembly1_P Structure of the 30S small ribosomal subunit from Mycobacterium smegmatis
7msh-assembly1_p 1.00 0.93 0.66 0.93 100% 70% / 100% 4.4e-17 sig 7msh-assembly1_p Mtb 70SIC in complex with MtbEttA at Pre_R1 state
7sfr-assembly1_p 1.00 0.97 0.55 0.97 100% 56% / 100% 3.6e-15 sig 7sfr-assembly1_p Unmethylated Mtb Ribosome 50S with SEQ-9

Foldseek search of the AlphaFold DB model (mean pLDDT 76.4, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 4

Upstream (5' on genome)Rv2908c (- strand, 7 bp gap)
Downstream (3' on genome)Rv2910c (- strand, 183 bp gap)
Predicted operon trmD · rimM · Rv2908c · rpsP

Neighbours from the H37Rv annotation (- strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) operon of 2: Rv2908c · rpsP — disagrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT2977) exponential phase: operon of 3, Rv2907c · Rv2908c · Rv2909c (coverage 94.74)
stationary phase: operon of 2, Rv2908c · Rv2909c (coverage 31.38) — disagrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (1 TF) ramB (represses)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: rplQ (50S ribosomal protein L17), high confidence (score 1000, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence). The pair's experimental or database support is transferred from orthologous pairs in other proteomes only: nothing was measured in M. tuberculosis, so it is an association inferred by orthology rather than measured in this organism.

Showing the 15 strongest of this gene's 240 partners at medium confidence (125 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 240 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv0634B rpmG2 exp (transferred) 50S ribosomal protein L33 999 1000 coexpression:696 experimental:999
Rv1015c rplY exp (transferred) 50S ribosomal protein L25/general stress protein Ctc 999 1000 coexpression:850 experimental:999
Rv1298 rpmE exp (transferred) 50S ribosomal protein L31 999 1000 coexpression:859 experimental:999 textmining:653
Rv2441c rpmA exp (transferred) 50S ribosomal protein L27 999 1000 coexpression:887 experimental:999
Rv0720 rplR exp (transferred) 50S ribosomal protein L18 999 1000 coexpression:826 experimental:999 textmining:657
Rv3456c rplQ exp (transferred) 50S ribosomal protein L17 999 1000 ctx cooccurence:484 coexpression:861 experimental:999
Rv0702 rplD exp (transferred) 50S ribosomal protein L4 999 1000 coexpression:863 experimental:999
Rv0719 rplF exp (transferred) 50S ribosomal protein L6 999 1000 coexpression:864 experimental:999 textmining:732
Rv3443c rplM exp (transferred) 50S ribosomal protein L13 999 1000 coexpression:963 experimental:999
Rv0056 rplI exp (transferred) 50S ribosomal protein L9 999 1000 coexpression:822 experimental:999
Rv0722 rpmD exp (transferred) 50S ribosomal protein L30 999 1000 coexpression:844 experimental:999 textmining:734
Rv2442c rplU exp (transferred) 50S ribosomal protein L21 999 1000 coexpression:886 experimental:999
Rv0707 rpsC exp (transferred) 30S ribosomal protein S3 999 1000 coexpression:851 experimental:999
Rv0723 rplO exp (transferred) 50S ribosomal protein L15 999 1000 coexpression:863 experimental:999
Rv0700 rpsJ exp (transferred) curated 30S ribosomal protein S10 999 1000 coexpression:861 experimental:999 database:844

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: 30S ribosomal protein S16
  • MTBC0 PGAP product: 30S ribosomal protein S16
  • Pfam (hmmscan --cut_ga): Ribosomal_S16 PF00886.25 (E=1e-22)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_217425.1)
  • Domains: Pfam-A via hmmscan --cut_ga — Ribosomal_S16 (PF00886.25)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0228
  • Curated reference: UniProt P9WH53 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 76.4)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 240 functional partner(s); context anchor rplQ
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_003091|Rv2909c|rpsP
MAVKIKLTRLGKIRNPQYRVAVADARTRRDGRAIEVIGRYHPKEEPSLIEINSERAQYWLSVGAQPTEPVLKLLKITGDWQKFKGLPGAQGRLKVAAPKPSKLEVFNAALAAADGGPTTEATKPKKKSPAKKAAKAAEPAPQPEQPDTPALGGEQAELTAES